Test Directory
| Test Code | |||
| MMP9 | |||
| Test Name | |||
| Matrix Metalloproteinase-9 | |||
| CPT Codes | |||
| 83520 | |||
| Expected Turnaround Time | |||
| 3 - 7 days | |||
| Clinical Utility | |||
|
MMP-9 is a marker of inflammation, tissue remodeling, wound healing, and mobilization of tissue-bound growth factors and cytokines. Its expression correlates with abnormal collagen deposition accompanying pancreatic cancer, with lymph node metastasis in breast cancer and with regional vessel invasion by giant cell tumor or bone. MMP-9 contributes to the pathogenesis of numerous clinical disease states, including rheumatic arthritis, coronary artery disease, chronic obstructive pulmonary disease, multiple sclerosis, asthma, and cancer. Current research is exploring the role of this enzyme as a potential drug target. |
|||
| Specimen and Container Info | |||
|
Specimen Type: Serum
Collection Container: Gold Top, Serum Separator Desired Specimen Volume: 1 mL |
|||
| Collection Instructions | |||
|
|||
| Processing and Submission Instructions | |||
|
|||
| Transport Instructions | |||
|
Transport to the laboratory frozen. |
|||
| Stability Requirements | |||
|
|||
| Methodology | |||
| ELISA | |||
| Reference Intervals | |||
|
See patient report. |
|||
| Limitations | |||
|
Results for this test are for research purposes only by the assay's manufacturer. The performance characteristics of this product have not been established. Results should not be used as a diagnostic procedure without confirmation of the diagnosis by another medically established diagnostic product or procedure. |
|||
| Reference Lab | |||
| Labcorp Of America Holdings | |||
| Testing Schedule | |||
| Varies | |||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.